US Stock MarketDetailed Quotes

Ascendis Pharma A/S (ASND)

Watchlist
  • 249.840
  • +1.290+0.52%
Close Apr 14 16:00 ET
  • 249.840
  • 0.0000.00%
Post 17:37 ET
15.48BMarket Cap-56.33P/E (TTM)

Ascendis Pharma A/S (ASND) Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(FY)Dec 31, 2025
(Q4)Dec 31, 2025
(Q3)Sep 30, 2025
(Q2)Jun 30, 2025
(Q1)Mar 31, 2025
(FY)Dec 31, 2024
(Q4)Dec 31, 2024
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities
117.60%53.9M
184.20%73.4M
103.84%2.15M
88.03%-7.34M
85.91%-14.31M
34.48%-306.2M
-105.26%-87.18M
54.99%-56.13M
59.96%-61.31M
30.92%-101.58M
Net income from continuing operations
39.69%-228.03M
12.76%-33.56M
38.52%-60.99M
64.48%-38.86M
27.79%-94.63M
21.47%-378.08M
55.72%-38.47M
38.85%-99.2M
9.92%-109.38M
-18.14%-131.04M
Operating gains losses
-181.67%-16.31M
-129.03%-1.33M
71.79%7.5M
-23.02%4.1M
-565.89%-26.58M
8.53%19.97M
56.20%4.58M
-35.52%4.37M
-28.56%5.32M
357.13%5.71M
Depreciation and amortization
-0.10%17.7M
7.80%4.82M
-8.12%4.02M
-1.82%4.31M
1.52%4.55M
-6.33%17.71M
-10.09%4.48M
-7.78%4.37M
-5.53%4.39M
-1.52%4.48M
Deferred tax
217.63%15.38M
531.98%6.86M
254.26%3.62M
1,580.35%3.85M
-57.70%1.06M
-33.68%4.84M
-81.26%1.09M
58.29%1.02M
153.38%229K
93.37%2.51M
Other non cash items
83.86%87.06M
8.24%35.3M
1,688.16%60.08M
24.57%-22.85M
-70.24%14.53M
2,306.38%47.35M
-20.40%32.61M
-119.10%-3.78M
-12.14%-30.3M
235.94%48.82M
Change In working capital
166.22%70.96M
134.86%39.86M
-69.86%24.64M
-93.78%-44.03M
197.39%50.49M
-7.39%-107.16M
-651.79%-114.35M
440.14%81.75M
37.83%-22.72M
-116.00%-51.84M
-Change in receivables
113.14%15.59M
92.35%-9.55M
-186.08%-24.91M
-318.68%-47.99M
968.62%98.03M
-261.90%-118.61M
-1,364.25%-124.8M
313.80%28.94M
-935.32%-11.46M
-17.46%-11.29M
-Change in inventory
93.17%-5.92M
101.66%501K
109.49%1.35M
44.32%-10.31M
110.69%2.54M
-10.76%-86.68M
-52.41%-30.18M
32.90%-14.23M
-8.50%-18.52M
-17.70%-23.75M
-Change in prepaid assets
-158.23%-6.05M
-201.19%-4.32M
19.18%5.07M
-122.18%-1.28M
-41.42%-5.52M
191.05%10.39M
182.51%4.27M
-34.95%4.26M
321.71%5.77M
61.64%-3.9M
-Change in payables and accrued expense
-138.47%-10.37M
-49.51%22.72M
-0.98%-7.53M
79.90%15.21M
-114.28%-40.77M
659.36%26.97M
547.56%44.99M
-273.90%-7.46M
271.83%8.45M
-233.64%-19.03M
-Change in other working capital
27.88%77.72M
453.27%30.51M
-27.89%50.66M
104.87%339K
-161.93%-3.79M
218.06%60.77M
-130.48%-8.64M
61,185.22%70.25M
35.77%-6.97M
254.72%6.13M
Cash from discontinued investing activities
Operating cash flow
117.60%53.9M
184.20%73.4M
103.84%2.15M
88.03%-7.34M
85.91%-14.31M
34.48%-306.2M
-105.26%-87.18M
54.99%-56.13M
59.96%-61.31M
30.92%-101.58M
Investing cash flow
Cash flow from continuing investing activities
-223.40%-8.49M
-783.07%-3.39M
89.46%-53K
-813.49%-4.34M
-109.83%-703K
-97.60%6.88M
-105.77%-384K
-102.26%-503K
-98.71%608K
-96.60%7.16M
Net PPE purchase and sale
-1,678.83%-8.49M
-785.38%-3.39M
89.46%-53K
-813.49%-4.34M
-253.27%-703K
80.05%-477K
-663.24%-383K
45.91%-503K
236.94%608K
81.66%-199K
Net investment purchase and sale
--0
--0
--0
--0
--0
-97.45%7.35M
-100.02%-1K
--0
--0
-96.53%7.35M
Cash from discontinued investing activities
Investing cash flow
-223.40%-8.49M
-783.07%-3.39M
89.46%-53K
-813.49%-4.34M
-109.83%-703K
-97.60%6.88M
-105.77%-384K
-102.26%-503K
-98.71%608K
-96.60%7.16M
Financing cash flow
Cash flow from continuing financing activities
-91.82%36.33M
9,689.66%8.52M
-90.92%38.85M
384.36%6.98M
-197.83%-18.02M
230.57%443.93M
101.44%87K
198.47%427.87M
-6.32%-2.46M
2,724.36%18.42M
Net issuance payments of debt
-117.88%-21.96M
-131.90%-6.83M
-105.00%-6.57M
-94.57%-5.49M
-10.05%-3.07M
-2.40%122.79M
52.93%-2.95M
-4.24%131.35M
-12.04%-2.82M
-8.49%-2.79M
Net common stock issuance
-105.61%-17.4M
--0
--0
--0
---17.4M
--309.91M
--19.29M
--290.62M
--0
--0
Proceeds from stock option exercised by employees
185.37%87.08M
405.97%15.35M
669.13%45.43M
3,315.89%12.47M
-34.77%13.83M
196.66%30.51M
50.35%3.03M
-4.65%5.91M
75.48%365K
1,036.60%21.21M
Net other financing activities
40.93%-11.4M
--0
--0
--0
---11.4M
-964.62%-19.29M
----
----
----
----
Cash from discontinued financing activities
Financing cash flow
-91.82%36.33M
9,689.66%8.52M
-90.92%38.85M
384.36%6.98M
-197.83%-18.02M
230.57%443.93M
101.44%87K
198.47%427.87M
-6.32%-2.46M
2,724.36%18.42M
Net cash flow
Beginning cash position
42.68%559.54M
-13.82%539.09M
90.98%494.05M
61.73%517.92M
42.68%559.54M
-11.83%392.16M
41.75%625.52M
-34.38%258.7M
-36.12%320.24M
-11.83%392.16M
Current changes in cash
-43.47%81.74M
189.77%78.52M
-88.97%40.95M
92.56%-4.7M
56.53%-33.04M
410.35%144.61M
-108.90%-87.47M
808.59%371.24M
41.78%-63.16M
-220.83%-76M
Effect of exchange rate changes
-210.85%-25.24M
-107.33%-1.58M
192.56%4.09M
-1,289.76%-19.18M
-310.35%-8.58M
479.01%22.77M
397.39%21.5M
-171.46%-4.42M
13.44%1.61M
163.87%4.08M
End cash Position
10.10%616.04M
10.10%616.04M
-13.82%539.09M
90.98%494.05M
61.73%517.92M
42.68%559.54M
42.68%559.54M
41.75%625.52M
-34.38%258.7M
-36.12%320.24M
Free cash flow
114.76%45.41M
179.95%70.01M
103.71%2.1M
81.06%-11.68M
85.25%-15.02M
34.52%-307.62M
-106.47%-87.56M
54.94%-56.63M
59.86%-61.65M
31.29%-101.78M
Currency Unit
EUR
EUR
EUR
EUR
EUR
EUR
EUR
EUR
EUR
EUR
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
Unqualified Opinion
--
--
--
--
Unqualified Opinion
--
--
--
--
(FY)Dec 31, 2025(Q4)Dec 31, 2025(Q3)Sep 30, 2025(Q2)Jun 30, 2025(Q1)Mar 31, 2025(FY)Dec 31, 2024(Q4)Dec 31, 2024(Q3)Sep 30, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities 117.60%53.9M184.20%73.4M103.84%2.15M88.03%-7.34M85.91%-14.31M34.48%-306.2M-105.26%-87.18M54.99%-56.13M59.96%-61.31M30.92%-101.58M
Net income from continuing operations 39.69%-228.03M12.76%-33.56M38.52%-60.99M64.48%-38.86M27.79%-94.63M21.47%-378.08M55.72%-38.47M38.85%-99.2M9.92%-109.38M-18.14%-131.04M
Operating gains losses -181.67%-16.31M-129.03%-1.33M71.79%7.5M-23.02%4.1M-565.89%-26.58M8.53%19.97M56.20%4.58M-35.52%4.37M-28.56%5.32M357.13%5.71M
Depreciation and amortization -0.10%17.7M7.80%4.82M-8.12%4.02M-1.82%4.31M1.52%4.55M-6.33%17.71M-10.09%4.48M-7.78%4.37M-5.53%4.39M-1.52%4.48M
Deferred tax 217.63%15.38M531.98%6.86M254.26%3.62M1,580.35%3.85M-57.70%1.06M-33.68%4.84M-81.26%1.09M58.29%1.02M153.38%229K93.37%2.51M
Other non cash items 83.86%87.06M8.24%35.3M1,688.16%60.08M24.57%-22.85M-70.24%14.53M2,306.38%47.35M-20.40%32.61M-119.10%-3.78M-12.14%-30.3M235.94%48.82M
Change In working capital 166.22%70.96M134.86%39.86M-69.86%24.64M-93.78%-44.03M197.39%50.49M-7.39%-107.16M-651.79%-114.35M440.14%81.75M37.83%-22.72M-116.00%-51.84M
-Change in receivables 113.14%15.59M92.35%-9.55M-186.08%-24.91M-318.68%-47.99M968.62%98.03M-261.90%-118.61M-1,364.25%-124.8M313.80%28.94M-935.32%-11.46M-17.46%-11.29M
-Change in inventory 93.17%-5.92M101.66%501K109.49%1.35M44.32%-10.31M110.69%2.54M-10.76%-86.68M-52.41%-30.18M32.90%-14.23M-8.50%-18.52M-17.70%-23.75M
-Change in prepaid assets -158.23%-6.05M-201.19%-4.32M19.18%5.07M-122.18%-1.28M-41.42%-5.52M191.05%10.39M182.51%4.27M-34.95%4.26M321.71%5.77M61.64%-3.9M
-Change in payables and accrued expense -138.47%-10.37M-49.51%22.72M-0.98%-7.53M79.90%15.21M-114.28%-40.77M659.36%26.97M547.56%44.99M-273.90%-7.46M271.83%8.45M-233.64%-19.03M
-Change in other working capital 27.88%77.72M453.27%30.51M-27.89%50.66M104.87%339K-161.93%-3.79M218.06%60.77M-130.48%-8.64M61,185.22%70.25M35.77%-6.97M254.72%6.13M
Cash from discontinued investing activities
Operating cash flow 117.60%53.9M184.20%73.4M103.84%2.15M88.03%-7.34M85.91%-14.31M34.48%-306.2M-105.26%-87.18M54.99%-56.13M59.96%-61.31M30.92%-101.58M
Investing cash flow
Cash flow from continuing investing activities -223.40%-8.49M-783.07%-3.39M89.46%-53K-813.49%-4.34M-109.83%-703K-97.60%6.88M-105.77%-384K-102.26%-503K-98.71%608K-96.60%7.16M
Net PPE purchase and sale -1,678.83%-8.49M-785.38%-3.39M89.46%-53K-813.49%-4.34M-253.27%-703K80.05%-477K-663.24%-383K45.91%-503K236.94%608K81.66%-199K
Net investment purchase and sale --0--0--0--0--0-97.45%7.35M-100.02%-1K--0--0-96.53%7.35M
Cash from discontinued investing activities
Investing cash flow -223.40%-8.49M-783.07%-3.39M89.46%-53K-813.49%-4.34M-109.83%-703K-97.60%6.88M-105.77%-384K-102.26%-503K-98.71%608K-96.60%7.16M
Financing cash flow
Cash flow from continuing financing activities -91.82%36.33M9,689.66%8.52M-90.92%38.85M384.36%6.98M-197.83%-18.02M230.57%443.93M101.44%87K198.47%427.87M-6.32%-2.46M2,724.36%18.42M
Net issuance payments of debt -117.88%-21.96M-131.90%-6.83M-105.00%-6.57M-94.57%-5.49M-10.05%-3.07M-2.40%122.79M52.93%-2.95M-4.24%131.35M-12.04%-2.82M-8.49%-2.79M
Net common stock issuance -105.61%-17.4M--0--0--0---17.4M--309.91M--19.29M--290.62M--0--0
Proceeds from stock option exercised by employees 185.37%87.08M405.97%15.35M669.13%45.43M3,315.89%12.47M-34.77%13.83M196.66%30.51M50.35%3.03M-4.65%5.91M75.48%365K1,036.60%21.21M
Net other financing activities 40.93%-11.4M--0--0--0---11.4M-964.62%-19.29M----------------
Cash from discontinued financing activities
Financing cash flow -91.82%36.33M9,689.66%8.52M-90.92%38.85M384.36%6.98M-197.83%-18.02M230.57%443.93M101.44%87K198.47%427.87M-6.32%-2.46M2,724.36%18.42M
Net cash flow
Beginning cash position 42.68%559.54M-13.82%539.09M90.98%494.05M61.73%517.92M42.68%559.54M-11.83%392.16M41.75%625.52M-34.38%258.7M-36.12%320.24M-11.83%392.16M
Current changes in cash -43.47%81.74M189.77%78.52M-88.97%40.95M92.56%-4.7M56.53%-33.04M410.35%144.61M-108.90%-87.47M808.59%371.24M41.78%-63.16M-220.83%-76M
Effect of exchange rate changes -210.85%-25.24M-107.33%-1.58M192.56%4.09M-1,289.76%-19.18M-310.35%-8.58M479.01%22.77M397.39%21.5M-171.46%-4.42M13.44%1.61M163.87%4.08M
End cash Position 10.10%616.04M10.10%616.04M-13.82%539.09M90.98%494.05M61.73%517.92M42.68%559.54M42.68%559.54M41.75%625.52M-34.38%258.7M-36.12%320.24M
Free cash flow 114.76%45.41M179.95%70.01M103.71%2.1M81.06%-11.68M85.25%-15.02M34.52%-307.62M-106.47%-87.56M54.94%-56.63M59.86%-61.65M31.29%-101.78M
Currency Unit EUREUREUREUREUREUREUREUREUREUR
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions Unqualified Opinion--------Unqualified Opinion--------
Market Insights
China Concept Stocks
View More
Middle East conflict spreads to the stock market! How should investors respond?
US President Trump stated in a recent interview that the US war with Iran has 'ended.' According to Axios, Pakistan, Egypt, and Turkey have Show More